My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone (HGH)
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Livewell Pharmaceuticals Livewell Pharmaceuticals
Tirzepatide
Tirzepatide - Livewell Pharmaceuticals

Tirzepatide - Livewell Pharmaceuticals

Brand:
Livewell Pharmaceuticals
Category:
Peptides
Substance:
Tirzepatide
Package:
10 mg
Price:
$140.00 - $140.00
See options
Product Overview
Tirzepatide (Mounjaro®) by Eli Lilly is a first-in-class dual GIP and GLP-1 receptor agonist that addresses both glucose regulation and weight loss in Type 2 Diabetes. Approved in the U.S. and Europe in 2022, it has demonstrated superior outcomes in HbA1c reduction and body weight management compared to GLP-1 therapies. The SURPASS-4 trial also noted lower mortality in T2D patients on tirzepatide during COVID-19. Its unique profile opens the door to broader use in obesity and metabolic disease management.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tirzepatide by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.

Products
Active Substances
  • Tirzepatide
 About Product
Tirzepatide
Livewell Pharmaceuticals
USA
$140.00
Show more
Reviews
Leave Review
FAQ
What hormones does Tirzepatide mimic?
It mimics GIP and GLP-1, two incretin hormones that help regulate insulin, appetite, and blood sugar.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Can it replace GLP-1 drugs like semaglutide?
It may in some cases, due to stronger efficacy in both glucose and weight control.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Is it used for Type 1 Diabetes?
No, it is currently indicated only for adults with Type 2 Diabetes
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.